Literature DB >> 25033742

Two siblings with early infantile myoclonic encephalopathy due to mutation in the gene encoding mitochondrial glutamate/H+ symporter SLC25A22.

Rony Cohen1, Lina Basel-Vanagaite2, Hadassah Goldberg-Stern3, Ayelet Halevy3, Avinoam Shuper3, Michal Feingold-Zadok4, Doron M Behar5, Rachel Straussberg6.   

Abstract

AIM: To characterize a new subset of early myoclonic encephalopathy usually associated with metabolic etiologies with a new genetic entity.
METHODS: We describe two siblings with early myoclonic encephalopathy born to consanguineous parents of Arab Muslim origin from Israel. We used homozygosity mapping and candidate gene sequencing to reveal the genetic basis of the myoclonic syndrome.
RESULTS: We found a rare missense mutation in the gene encoding one of the two mitochondrial glutamate/H symporters, SLC25A22. The phenotype of early myoclonic encephalopathy was first linked to the same mutation in 2005 in patients of the same ethnicity as our family.
CONCLUSIONS: Owing to the devastating nature of this encephalopathy, we focus attention on its clinical history, epileptic semiology, distinct electroencephalography features, and genetic basis. We provide the evidence that an integrated diagnostic strategy combining homozygosity mapping with candidate gene sequencing is efficient in consanguineous families with highly heterogeneous autosomal recessive diseases.
Copyright © 2014 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Myoclonic encephalopathy; SLC25A22 mutation

Mesh:

Substances:

Year:  2014        PMID: 25033742     DOI: 10.1016/j.ejpn.2014.06.007

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  9 in total

Review 1.  Epileptic encephalopathies: new genes and new pathways.

Authors:  Sahar Esmaeeli Nieh; Elliott H Sherr
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

2.  Report on three additional patients and genotype-phenotype correlation in SLC25A22-related disorders group.

Authors:  Camille Lemattre; Marion Imbert-Bouteille; Vincent Gatinois; Paule Benit; Elodie Sanchez; Thomas Guignard; Frédéric Tran Mau-Them; Emmanuelle Haquet; François Rivier; Emilie Carme; Agathe Roubertie; Anne Boland; Doris Lechner; Vincent Meyer; Julien Thevenon; Yannis Duffourd; Jean-Baptiste Rivière; Jean-François Deleuze; Constance Wells; Florence Molinari; Pierre Rustin; Patricia Blanchet; David Geneviève
Journal:  Eur J Hum Genet       Date:  2019-07-08       Impact factor: 4.246

Review 3.  Current Treatment Options for Early-Onset Pediatric Epileptic Encephalopathies.

Authors:  Rolla Shbarou
Journal:  Curr Treat Options Neurol       Date:  2016-10       Impact factor: 3.598

4.  Inhibition of the Mitochondrial Glutamate Carrier SLC25A22 in Astrocytes Leads to Intracellular Glutamate Accumulation.

Authors:  Emmanuelle Goubert; Yanina Mircheva; Francesco M Lasorsa; Christophe Melon; Emanuela Profilo; Julie Sutera; Hélène Becq; Ferdinando Palmieri; Luigi Palmieri; Laurent Aniksztejn; Florence Molinari
Journal:  Front Cell Neurosci       Date:  2017-05-31       Impact factor: 5.505

5.  Mutations in SLC25A22: hyperprolinaemia, vacuolated fibroblasts and presentation with developmental delay.

Authors:  Emma S Reid; Hywel Williams; Glenn Anderson; Malika Benatti; Kling Chong; Chela James; Louise Ocaka; Cheryl Hemingway; Daniel Little; Richard Brown; Alasdair Parker; Simon Holden; Emma Footitt; Shamima Rahman; Paul Gissen; Philippa B Mills; Peter T Clayton
Journal:  J Inherit Metab Dis       Date:  2017-03-02       Impact factor: 4.982

6.  A de novo missense mutation of GABRB2 causes early myoclonic encephalopathy.

Authors:  Atsushi Ishii; Jing-Qiong Kang; Cara C Schornak; Ciria C Hernandez; Wangzhen Shen; Joseph C Watkins; Robert L Macdonald; Shinichi Hirose
Journal:  J Med Genet       Date:  2016-10-27       Impact factor: 6.318

Review 7.  Transport of L-Arginine Related Cardiovascular Risk Markers.

Authors:  Sofna Banjarnahor; Roman N Rodionov; Jörg König; Renke Maas
Journal:  J Clin Med       Date:  2020-12-08       Impact factor: 4.241

Review 8.  Advancing epilepsy genetics in the genomic era.

Authors:  Candace T Myers; Heather C Mefford
Journal:  Genome Med       Date:  2015-08-25       Impact factor: 11.117

9.  CRISPR-Mediated Induction of Neuron-Enriched Mitochondrial Proteins Boosts Direct Glia-to-Neuron Conversion.

Authors:  Gianluca L Russo; Giovanna Sonsalla; Poornemaa Natarajan; Christopher T Breunig; Giorgia Bulli; Juliane Merl-Pham; Sabine Schmitt; Jessica Giehrl-Schwab; Florian Giesert; Martin Jastroch; Hans Zischka; Wolfgang Wurst; Stefan H Stricker; Stefanie M Hauck; Giacomo Masserdotti; Magdalena Götz
Journal:  Cell Stem Cell       Date:  2020-11-16       Impact factor: 24.633

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.